Moreover, activation of PPARα ameliorates liver fibrosis and inhibits the function of hepatocyte-specific G-protein pathway suppressor 2 (GPS2), alleviating the development of diet-induced steatosis and fibrosis and causing activation of lipid catabolic genes [32,33]. The gene discussed is GPS2; the disease is steatosis.